MMM · 3M Company

3M’s Q1 2026 results reflect a pronounced divergence between GAAP and adjusted metrics, driven by $0.91 per share in special items—including $0.18 from manufactured PFAS products, $0.67 from the change in value of Solventum ownership, and $0.04 from significant litigation—explaining the 40% YoY GAAP EPS decline. Adjusted EPS of $2.14 grew 14% YoY, supported by 1.2% adjusted organic sales growth and a 30-basis-point expansion in adjusted operating margin to 23.8%, signaling continued execution on cost discipline and portfolio simplification despite a 1.4% decline in GAAP organic sales. Segment-level analysis shows strength in China (+8.6% total sales) and EMEA (+6.7%), offset by weakness in the Americas (−1.7%) and Consumer segment (0.6% growth). Management reaffirmed full-year 2026 guidance, targeting $8.50–$8.70 adjusted EPS, ~4% adjusted sales growth, and 70–80 bps adjusted operating margin expansion—underscoring confidence in structural improvements amid ongoing PFAS liabilities and Solventum-related volatility. The $2.4 billion returned to shareholders in Q1 reflects sustained capital return commitment, while $0.6 billion in operating cash flow and $0.5 billion in adjusted free cash flow demonstrate liquidity resilience despite working capital headwinds reflected in the $1.5 billion decline in cash and cash equivalents. Forward-looking statements in the release explicitly cite PFAS liabilities, Solventum spin-off impacts, and macroeconomic volatility as key uncertainties.